Mtm-H-001

Systemic Lupus Erthematosus (SLE)

Beijing GoBroad HospitalN/AActive

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

22 Active assets in the Systemic Lupus Erthematosus (SLE) cohort.

Asset / Sponsor	Phase	Rating
Prasterone National Center for Research Resources (NCRR)	Phase 3	BB
Rivaroxaban University College, London	Phase 2	B
Cytosin-Arabinosid National Center for Research Resources (NCRR)	Phase 2	B
WARFARIN University College, London	Phase 2	B
TECHNETATE(3-)-99TC, (N-(4-(((2-AMINO-1,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-D-.GAMMA.-GLUTAMYL-(2S)-2-(AMINO-.KAPPA.N)-.BETA.-ALANYL-L-.ALPHA.-ASPARTYL-.KAPPA.N-L-CYSTEINATO(6-)-.KAPPA.N,.KAPPA.S)OXO-, HYDROGEN (1:3), (SP-5-24)- Mayo Clinic	Phase 2	B